Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), showed decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), showed decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
2181
-
2182
-
2183
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2184
-
2185
-
2186
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2187
-
2188
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2189
-
2190
-
2191
-
2192
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2193
-
2194
-
2195
-
2196
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2197
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2198
-
2199
-
2200
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: